No Data
No Data
No Data
No Data
No Data
Hainan Haiyao's Antibiotic Passes Generic Evaluation
Hainan Haiyao (SHE:000566) said its cefuroxime sodium for injection, an antibiotic, has passed China's national generic drug quality and efficacy consistency evaluation. The antibiotic is indicated fo
MT NewswiresJan 31 14:51
Hainan Haiyao's Unit Gets Nod to Become Marketing License Holder of Shuangshen Huoxue Tongluo Granules
China's National Medical Products Administration approved Hainan Haiyao's (SHE:000566) unit, Haikou Pharmaceutical Factory, to become the drug marketing license holder of the Shuangshen Huoxue Tongluo
MT NewswiresDec 8, 2023 17:07
Hainan Haiyao Unit Receives 1.2 Million Yuan Government Subsidy
Hainan Haiyao (SHE:000566) has received 1.2 million yuan in government subsidy from the local government of Haikou City in China's Hainan province. The subsidy was issued in relation to the company's
MT NewswiresAug 21, 2023 19:51
Hainan Haiyao Unit's Minocycline Hydrochloride Capsules Passes Drug Regulator's Evaluation
04:55 AM EST, 03/08/2023 (MT Newswires) -- Haikou Pharmaceutical Factory, a unit of Hainan Haiyao (SHE:000566), received notification that minocycline hydrochloride capsules passed the consistency eva
MT NewswiresMar 8, 2023 17:56
Hainan Haiyao Unit Gets Regulatory Nod for Antibacterial Drug
02:33 AM EST, 01/31/2023 (MT Newswires) -- Haikou Pharmaceutical Factory, a subsidiary of Hainan Haiyao (SHE:000566), received approval from China's National Medical Products Administration for its ce
MT NewswiresJan 31, 2023 15:34
Hainan Haiyao Gets Regulatory Nod for Anti-Skin Disease Drug
05:12 AM EST, 01/09/2023 (MT Newswires) -- Hainan Haiyao (SHE:000566) unit Haikou Pharmaceutical Factory obtained regulatory approval for the registration of desloratadine oral solution drug. The drug
MT NewswiresJan 9, 2023 18:14
No Data
No Data